Barclays
CO

Barclays’s Global Cord Blood Corporation CO Stock Holding History

Barclays’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-204,942
Closed -$957K – 4984
2021
Q3 		$957K Buy
204,942
+23,885
+13% +$117K ﹤0.01% 2818
2021
Q2 		$967K Buy
181,057
+86,925
+92% +$455K ﹤0.01% 2680
2021
Q1 		$426K Buy
+94,132
New +$408K ﹤0.01% 3273
2019
Q4 		– Sell
-4,488
Closed -$22K – 7201
2019
Q3 		$22K Buy
+4,488
New +$23.5K ﹤0.01% 6195
2019
Q2 		– Sell
-6
Closed – – 7579
2019
Q1 		$0 Buy
+6
New +$40 ﹤0.01% 7650
2018
Q2 		– Sell
-1,181
Closed -$12K – 7621
2018
Q1 		$12K Buy
+1,181
New +$12.1K ﹤0.01% 6618
2017
Q3 		– Sell
-2,000
Closed -$19K – 7235
2017
Q2 		$19K Buy
+2,000
New +$16K ﹤0.01% 5827
2016
Q4 		– Sell
-3,440
Closed -$18K – 7019
2016
Q3 		$18K Sell
3,440
-5,960
-63% -$31.8K ﹤0.01% 5546
2016
Q2 		$54K Sell
9,400
-4,400
-32% -$26.8K ﹤0.01% 4790
2016
Q1 		$83K Sell
13,800
-600
-4% -$3.58K ﹤0.01% 4484
2015
Q4 		$86K Buy
+14,400
New +$90.9K ﹤0.01% 4494
2013
Q3 		– Sell
-41
Closed – – 7747
2013
Q2 		$0 Buy
+41
New +$117 ﹤0.01% 7679

Other funds holding CO

OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Barclays's CO Position: Q4 2021 in Review

Barclays sold out of Global Cord Blood Corporation (CO) in Q4 2021, closing a stake of 204,942 shares — an estimated $957K sold.

Barclays first reported a position in CO in Q2 2013 and held it in 12 quarters. The position peaked at $967K in Q2 2021. 28 funds tracked by Wall St. Rank hold CO as of Q4 2021.

  • Barclays reported no remaining Global Cord Blood Corporation position as of Q4 2021 after selling out during the quarter.
  • Barclays sold 204,942 Global Cord Blood Corporation shares in Q4 2021, an estimated $957K.
  • Barclays first reported a position in Global Cord Blood Corporation in Q2 2013 and held it in 12 quarters.
  • Barclays's Global Cord Blood Corporation position peaked at $967K in Q2 2021.
  • 28 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2021.

Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.